Timothy L. Moore's most recent trade in Cerus Corp. was a trade of 60,000 Common Stock done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cerus Corp. | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 60,000 | 205,073 (0%) | 0% | 0 | Common Stock | |
| Biolife Solutions Inc | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 6,876 | 36,773 (0%) | 0% | - | Common Stock | |
| Allogene Therapeutics Inc | Timothy L. Moore | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 1.71 per share. | 03 Feb 2025 | 14,746 | 250,713 (0%) | 0% | 1.7 | 25,216 | Common Stock |
| Cerus Corp. | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 5.00 per share. | 05 Jun 2024 | 40,000 | 145,073 (0%) | 0% | 5 | 200,000 | Common Stock |
| Allogene Therapeutics Inc | Timothy L. Moore | Chief Technical Officer | 22 Apr 2024 | 17,360 | 265,459 (0%) | 0% | 3.5 | 60,189 | Common Stock | |
| Biolife Solutions Inc | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 11,264 | 29,897 (0%) | 0% | - | Common Stock | |
| Allogene Therapeutics Inc | Moore Timothy L. | Chief Technical Officer | 25 Jan 2024 | 341,515 | 341,515 | - | - | Stock Option (Right to buy) | ||
| Allogene Therapeutics Inc | L. Timothy Moore | Chief Technical Officer | 25 Jan 2024 | 96,600 | 282,819 (0%) | 0% | 0 | Common Stock | ||
| Cerus Corp. | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 5.00 per share. | 07 Jun 2023 | 40,000 | 105,073 (0%) | 0% | 5 | 200,000 | Common Stock |
| Allogene Therapeutics Inc | Timothy L. Moore | Chief Technical Officer | 24 Apr 2023 | 831,024 | 831,024 | - | - | Stock Option (Right to Buy) | ||
| Allogene Therapeutics Inc | Timothy L. Moore | Chief Technical Officer | 24 Apr 2023 | 186,219 | 186,219 (0%) | 0% | 0 | Common Stock | ||
| Biolife Solutions Inc | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,187 | 17,776 (0%) | 0% | - | Common Stock | |
| Instil Bio Inc | Timothy L. Moore | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 750,000 | 750,000 | - | - | Employee Stock Option (right to buy) | |
| Biolife Solutions Inc | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 7,589 | 7,589 (0%) | 0% | - | Common Stock | |
| Cerus Corp. | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 39,866 | 39,866 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 20,454 | 65,073 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp. | Timothy L. Moore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2021 | 4,296 | 0 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Timothy L. Moore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2021 | 4,296 | 44,619 (0%) | 0% | - | Common Stock | |
| Cerus Corp. | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 29,983 | 29,983 | - | - | Option (Right to Buy) | |
| Cerus Corp. | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 14,888 | 40,323 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp. | Timothy L. Moore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 13,228 | 0 | - | - | Restricted Stock Unit | |
| Cerus Corp. | Timothy L. Moore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 13,228 | 25,435 (0%) | 0% | - | Common Stock | |
| Cerus Corp. | Timothy L. Moore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2020 | 4,296 | 12,207 (0%) | 0% | - | Common Stock | |
| Cerus Corp. | Timothy L. Moore | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Sep 2020 | 4,296 | 4,296 | - | - | Restricted Stock Unit |